These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37967621)

  • 1. Opioid toxicity deaths in Black persons who experienced provincial incarceration in Ontario, Canada 2015-2020: A population-based study.
    Owusu-Bempah A; Nicholson HL; Butler A; Croxford R; Kouyoumdjian FG
    Prev Med; 2023 Dec; 177():107778. PubMed ID: 37967621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015-2020: a whole population retrospective cohort study.
    Butler A; Croxford R; Bodkin C; Akbari H; Bayoumi AM; Bondy SJ; Guenter D; McLeod KE; Gomes T; Kanagalingam T; Kiefer LA; Orkin AM; Owusu-Bempah A; Regenstreif L; Kouyoumdjian F
    BMJ Open; 2023 May; 13(5):e071867. PubMed ID: 37164452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of COVID-19 on opioid toxicity deaths for people who experience incarceration compared to the general population in Ontario: A whole population data linkage study.
    Butler A; Croxford R; McLeod KE; Gomes T; Orkin AM; Bondy SJ; Kouyoumdjian FG
    PLoS One; 2023; 18(10):e0293251. PubMed ID: 37874825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015-2018: a repeated cross-sectional analysis.
    Bodkin C; Bondy S; Regenstreif L; Kiefer L; Kouyoumdjian F
    BMJ Open; 2021 Nov; 11(11):e048944. PubMed ID: 34794988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.
    Russell C; Nafeh F; Pang M; MacDonald SF; Derkzen D; Rehm J; Fischer B
    BMC Public Health; 2022 Mar; 22(1):436. PubMed ID: 35246083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner's Cases.
    Groot E; Kouyoumdjian FG; Kiefer L; Madadi P; Gross J; Prevost B; Jhirad R; Huyer D; Snowdon V; Persaud N
    PLoS One; 2016; 11(7):e0157512. PubMed ID: 27384044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Punitive discontinuation of opioid agonist therapy during incarceration.
    Marmel A; Bozinoff N
    Int J Prison Health; 2020 Aug; 16(4):337-342. PubMed ID: 33634666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
    Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
    J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release.
    McLeod KE; Buxton JA; Karim ME; Martin RE; Nosyk B; Kurz M; Scow M; Felicella G; Slaunwhite AK
    PLoS One; 2024; 19(7):e0306075. PubMed ID: 38985687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey.
    Kouyoumdjian FG; Patel A; To MJ; Kiefer L; Regenstreif L
    PLoS One; 2018; 13(2):e0192431. PubMed ID: 29447177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality over 12 years of follow-up in people admitted to provincial custody in Ontario: a retrospective cohort study.
    Kouyoumdjian FG; Kiefer L; Wobeser W; Gonzalez A; Hwang SW
    CMAJ Open; 2016; 4(2):E153-61. PubMed ID: 27398358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-related deaths in Ontario correctional facilities and penitentiaries (2009-2019).
    Button L; Williams AS; Lamparter C; Woodall KL
    Forensic Sci Med Pathol; 2023 Sep; 19(3):357-363. PubMed ID: 36690802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder.
    Michener PS; Bianchet E; Fox S; Evans EA; Friedmann PD
    Harm Reduct J; 2024 Jul; 21(1):138. PubMed ID: 39034384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
    Treitler PC; Enich M; Reeves D; Crystal S
    Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
    [No Abstract]   [Full Text] [Related]  

  • 16. Do people who experience incarceration age more quickly? Exploratory analyses using retrospective cohort data on mortality from Ontario, Canada.
    Kouyoumdjian FG; Andreev EM; Borschmann R; Kinner SA; McConnon A
    PLoS One; 2017; 12(4):e0175837. PubMed ID: 28410398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdose and substance-related mortality after release from prison in Washington State: 2014-2019.
    O'Connor AW; Sears JM; Fulton-Kehoe D
    Drug Alcohol Depend; 2022 Dec; 241():109655. PubMed ID: 36283246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior opiate injection and incarceration history predict injection drug use among inmates.
    Calzavara LM; Burchell AN; Schlossberg J; Myers T; Escobar M; Wallace E; Major C; Strike C; Millson M
    Addiction; 2003 Sep; 98(9):1257-65. PubMed ID: 12930213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of overdose-related death for people with a history of incarceration.
    Gan WQ; Kinner SA; Nicholls TL; Xavier CG; Urbanoski K; Greiner L; Buxton JA; Martin RE; McLeod KE; Samji H; Nolan S; Meilleur L; Desai R; Sabeti S; Slaunwhite AK
    Addiction; 2021 Jun; 116(6):1460-1471. PubMed ID: 33047844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
    Bozinoff N; DeBeck K; Milloy MJ; Nosova E; Fairbairn N; Wood E; Hayashi K
    Drug Alcohol Depend; 2018 Dec; 193():42-47. PubMed ID: 30340144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.